HACKENSACK MERIDIAN HEALTH
- Country
- ๐บ๐ธUnited States
- Ownership
- -
- Established
- 2016-01-01
- Employees
- -
- Market Cap
- -
Trial of Exercise to Reduce Cancer Related Fatigue in Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2016-07-27
- Last Posted Date
- 2022-09-07
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 24
- Registration Number
- NCT02846389
- Locations
- ๐บ๐ธ
Hackensack University Medical Center, Hackensack, New Jersey, United States
Single Agent and Combined Inhibition After Allogeneic Stem Cell Transplant
- Conditions
- Interventions
- First Posted Date
- 2016-07-27
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 8
- Registration Number
- NCT02846376
- Locations
- ๐บ๐ธ
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States
Check Point Inhibition After Autologous Stem Cell Transplantation in Patients at High Risk of Post Transplant Recurrence
- First Posted Date
- 2016-02-12
- Last Posted Date
- 2024-06-17
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 35
- Registration Number
- NCT02681302
- Locations
- ๐บ๐ธ
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center, Washington, District of Columbia, United States
๐บ๐ธHackensack University medical Center, Hackensack, New Jersey, United States
A Pilot Study of the Therapeutic Potential of Stem Cell Educator Therapy in Type 1 Diabetes
- Conditions
- Interventions
- First Posted Date
- 2015-12-08
- Last Posted Date
- 2024-10-10
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 13
- Registration Number
- NCT02624804
- Locations
- ๐บ๐ธ
Hackensack University Medical Center - John Theurer Cancer Center, Hackensack, New Jersey, United States
Start Time Optimization of Biologics in Polyarticular JIA
- Conditions
- First Posted Date
- 2015-10-30
- Last Posted Date
- 2021-02-05
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 400
- Registration Number
- NCT02593006
- Locations
- ๐บ๐ธ
Emory Children's Center, Atlanta, Georgia, United States
๐บ๐ธUniversity of Vermont Medical Center, Burlington, Vermont, United States
๐จ๐ฆThe Hospital for Sick Children, Toronto, Ontario, Canada
Dose Finding Study of Ibrutinib Plus Lenalidomide / Rituximab in Relapsed or Refractory Mantle Cell Lymphoma
- Conditions
- Interventions
- First Posted Date
- 2015-05-18
- Last Posted Date
- 2024-02-22
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 27
- Registration Number
- NCT02446236
- Locations
- ๐บ๐ธ
The Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States
TacTIC- Trans-disciplinary Chronic Disease Continuity of Care Model
- Conditions
- Interventions
- First Posted Date
- 2015-03-26
- Last Posted Date
- 2018-08-08
- Lead Sponsor
- Hackensack Meridian Health
- Registration Number
- NCT02398851
- Locations
- ๐บ๐ธ
Hackensack University Medical center, Hackensack, New Jersey, United States
The "Peripheral Access Utilizing Sonographic Evaluation" Study
- Conditions
- Interventions
- First Posted Date
- 2015-02-10
- Last Posted Date
- 2018-08-03
- Lead Sponsor
- Hackensack Meridian Health
- Registration Number
- NCT02360163
- Locations
- ๐บ๐ธ
Hackensack University Medical center, Hackensack, New Jersey, United States
Study of TelmisartanFor the Prevention of Acute GVHD Post Allogeneic Hematopoietic Stem Cell Transplantation
- First Posted Date
- 2015-01-14
- Last Posted Date
- 2024-05-01
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 32
- Registration Number
- NCT02338232
- Locations
- ๐บ๐ธ
Hackensack University Medical Center, Hackensack, New Jersey, United States
The IMPROVE Study-IMPact of a Regulated ADC System
- Conditions
- First Posted Date
- 2014-08-29
- Last Posted Date
- 2015-03-17
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 120
- Registration Number
- NCT02228694
- Locations
- ๐บ๐ธ
Hackensack University Medical center, Hackensack, New Jersey, United States